HIT Consultant September 12, 2023
Fred Pennic

What You Should Know:

  • Bold, a Los Angeles-based healthy aging platform raises $17M in Series A funding led by Rethink Impact, with participation from Samsung Next and existing investors Andreessen Horowitz (a16z) Bio + Health, Khosla Ventures, GingerBread Capital, and Primetime Partners. The latest funding, bringing its total amount raised to $27M.
  • The company plans to utilize the capital to support Bold’s continued expansion with national and regional Medicare plans and provider groups, and accelerate the growth of its clinical exercise offerings to support the diverse physical and mental health needs of older adults.

Reduce falls, increase activity, improve satisfaction

1 in 3 adults over 65 falls every year. Founded in 2020, Bold provides each member...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Investments, Medicare, Trends
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article